Glioblastoma Clinical Trials in Anaheim, CA

Glioblastoma Clinical Trials in Anaheim, CA

View the best 10 glioblastoma medical studies in Anaheim, California. Access promising new therapies by applying to a Anaheim-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Anaheim, California

Here are the top 10 medical studies for glioblastoma in Anaheim, California

Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of Littleton Adventist Hospital in Littleton, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Image of Valkyrie Clinical Trials in Beverly Hills, United States.

Pemigatinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a drug called pemigatinib for people with recurrent glioblastoma or other primary brain tumors. Pemigatinib will be given daily on a 2-week on, 1-week off schedule. The trial will enroll about 82 people in each of 3 cohorts.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of Children's Hospital of Alabama in Birmingham, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in DNA damage repair genes.
Image of START Midwest, LLC in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer drug, NGM707, as a possible treatment for advanced solid tumors. It will be tested alone and in combination with another cancer drug, pembrolizumab.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of City of Hope Medical Center in Duarte, United States.

Irinotecan +1 More

Topoisomerase I inhibitor

Recruiting1 awardPhase 1
This trial is testing the side effects and best dose of carboxylesterase-expressing allogeneic neural stem cells given with irinotecan hydrochloride for high-grade gliomas. The hope is that the genetically modified neural stem cells will make the tumor more sensitive to the irinotecan hydrochloride, which may stop the growth of the tumor cells.
Image of University of California, Los Angeles in Los Angeles, United States.

Temozolomide +1 More

Anti-cancer agent

Recruiting1 awardPhase 1 & 2
This trial will study the safety and effectiveness of a new drug, AQ4N, for treating Huntington's disease.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

APX005M

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial studies the side effects and best dose of APX005M in treating younger patients with primary malignant central nervous system tumor.

Popular filter options for glioblastoma anaheim trials

Clinical Trials With No Placebo

View 63 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.